MedPath

Evaluation of lipid metabolism-improving effects by taking a single dose of test beverage

Not Applicable
Conditions
Healthy male adults
Registration Number
JPRN-UMIN000043326
Lead Sponsor
CPCC Company Limited
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
Male
Target Recruitment
40
Inclusion Criteria

Not provided

Exclusion Criteria

(1) Subjects with previous and/or current medical history of serious diseases in circulatory/respiratory/digestive/urinary organs. (2) Throughout this trial, subjects who have any difficulty in refraining from taking steadily in the medicines (related to blood pressure, fatigue, lipid, and/or allergic rhinitis), which might affect the test results. (3) Subjects taking steadily in the following foods that might affect their test result; health-specific, functional, health foods (related to blood pressure, blood stream, exercise fatigue, metabolism-improving, poor blood flow-improving, fat combustion and/or lipolysis), supplementary one, vitamin tablet and nutrient, with any difficulty in refraining from having those during this trial. (4) Subjects who take excessive alcohol. (5) Subjects with any possibility of hindrance to this trial, owing to their allergic rhinitis. (6) Subjects who are now under the other clinical tests with some kind of medicine/food, or participated in those tests within four weeks before this trial. (7) Subjects falling into the habit of smoking. (8) Subjects suffering from severe anemia. (9) Subjects having drug and/or food allergy. (10) Subjects who donated over 200 mL of their whole blood and/or blood components within a month before this trial. (11) Subjects who donated over 400 mL of their whole blood within the last three months before this trial. (12) Subjects who will be collected over 1200 mL of their blood within the last twelve months before this trial. (13) Others who have been determined as ineligible for participation, judging from the principal/sub investigator's opinions.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath